Come up with a name for your new list and we'll add to it:
Ecrins Therapeutics raised a round of funding on September 14, 2017. Investors include
Business Angels des Grandes Ecoles.
Ecrins Therapeutics specializes in the discovery and development of oncology drugs. The company's main drug candidate ET-D5 is being developped for human and veterinary oncology applications.…